Optiver Holding
CLB icon

Optiver Holding’s Core Laboratories CLB Stock Holding History

Optiver Holding’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-170
Closed -$2.73K – 2388
2025
Q4 		$2.73K Buy
+170
New +$2.53K ﹤0.01% 1818
2022
Q4 		– Sell
-253
Closed -$4K – 453
2022
Q3 		$4K Buy
+253
New +$4.26K ﹤0.01% 366

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's CLB Position: Q1 2026 in Review

Optiver Holding sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 170 shares — an estimated $2.73K sold.

Optiver Holding first reported a position in CLB in Q3 2022 and held it in 2 quarters. The position peaked at $4K in Q3 2022. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Optiver Holding reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 170 Core Laboratories shares in Q1 2026, an estimated $2.73K.
  • Optiver Holding first reported a position in Core Laboratories in Q3 2022 and held it in 2 quarters.
  • Optiver Holding's Core Laboratories position peaked at $4K in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.